We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

PictureRx: An Intervention to Reduce Latino Health Disparities (Supplement: Medical Icons)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01618461
First Posted: June 13, 2012
Last Update Posted: June 13, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
National Institute on Minority Health and Health Disparities (NIMHD)
Information provided by (Responsible Party):
M Brian Riley, PictureRx, LLC
  Purpose
Research shows that well-developed icons and other pictorials aid in the comprehension of medication information and are effective in improving patients' medication management. This experimental study seeks to test the effect of icons and structured medication information on subjects' processing and recall of simulated medication instructions in a computer testing environment. The study planned to enroll 200 subjects.

Condition Intervention
Understanding of Medication Instructions Recall of Medication Instructions Behavioral: Drug indication icons Behavioral: Structured instructions

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Health Services Research
Official Title: PictureRx: An Intervention to Reduce Latino Health Disparities (Supplement: Medical Icons)

Further study details as provided by M Brian Riley, PictureRx, LLC:

Primary Outcome Measures:
  • Understanding of medication instructions [ Time Frame: Within 10-20 minutes ]
    Participants' ability to state the drug indication


Secondary Outcome Measures:
  • Recall of medication instructions [ Time Frame: Within 10-20 minutes ]
    Participants' ability to recall the instructions after viewing a series of medications


Enrollment: 200
Study Start Date: June 2011
Study Completion Date: July 2011
Primary Completion Date: July 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: Text instructions
Medication instructions displayed in text format
Experimental: Drug indication icons
Icons illustrate the purpose of each medication
Behavioral: Drug indication icons
Icons illustrate the purpose of each medication
Experimental: Structured instructions
Graphical format shows what time(s) of day each medication should be taken
Behavioral: Structured instructions
Graphical format shows what time(s) of day each medication should be taken
Experimental: Icons + Structured instructions
Icons illustrate the purpose of each medication, and a graphical format shows what time(s) of day each medication should be taken
Behavioral: Drug indication icons
Icons illustrate the purpose of each medication
Behavioral: Structured instructions
Graphical format shows what time(s) of day each medication should be taken

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Be at least 18 years old
  • Fluency in English or Spanish
  • Manage their own prescription medicines, and
  • Be taking at least one chronic medication

Exclusion Criteria:

  • Too ill to complete the experiment
  • Having visual acuity worse than 20/50 via Rosenbaum Visual Acuity exam (eyechart)
  • Inability to communicate in either Spanish or English
  • Overt psychiatric illnesses, overt delirium or dementia
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01618461


Locations
United States, Tennessee
Saint Thomas Family Health Center - West
Nashville, Tennessee, United States, 37209
Saint Thomas Family Health Center - South
Nashville, Tennessee, United States, 37211
Sponsors and Collaborators
PictureRx, LLC
National Institute on Minority Health and Health Disparities (NIMHD)
Investigators
Principal Investigator: M Brian Riley, MA PictureRx, LLC
  More Information

Responsible Party: M Brian Riley, Director of Research, PictureRx, LLC
ClinicalTrials.gov Identifier: NCT01618461     History of Changes
Other Study ID Numbers: 3R43MD004048-02S1 ( U.S. NIH Grant/Contract )
First Submitted: June 11, 2012
First Posted: June 13, 2012
Last Update Posted: June 13, 2012
Last Verified: June 2012

Keywords provided by M Brian Riley, PictureRx, LLC:
Prescription drug information
Medication management

Additional relevant MeSH terms:
Immunoconjugates
Immunologic Factors
Physiological Effects of Drugs